Concerns about talc-containing products were the basis for a March 12 hearing convened by a House Oversight and Reform subcommittee, but the larger discussion pertained to the regulatory framework for cosmetics and FDA’s authorities – or lack thereof – under current law.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?